Sugarloaf Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-57	Closed	-$3.02K	–	715
2024 Q2	$3.02K	Hold	57	–	–	﹤0.01%	562
2024 Q1	$4.67K	Buy	+57	New	+$4.67K	﹤0.01%	543